Revising the ECRIN standard requirements for information technology and data management in clinical trials by Christian Ohmann et al.
TRIALS
Ohmann et al. Trials 2013, 14:97
http://www.trialsjournal.com/content/14/1/97UPDATE Open AccessRevising the ECRIN standard requirements for
information technology and data management in
clinical trials
Christian Ohmann1*, Steve Canham2, Catherine Cornu3, Jochen Dreß4, François Gueyffier5, Wolfgang Kuchinke1,
Enrico B Nicolis6 and Michael Wittenberg7Abstract
The pilot phase of the ECRIN (European Clinical Research Infrastructure Network) certification programme for
European data centres, in late 2011, led to a substantial revision of the original ECRIN standards, completed by June
2012. The pilot phase, the conclusions drawn from it and the revised set of standards are described. Issues
concerning the further development of standards and related material are discussed, as are the methods available
to best support that development. A strategy is outlined based on short-lived specific task groups, established as
necessary by a steering group drawn from ECRIN-ERIC. A final section discusses possible future developments.
Keywords: Standards, Information technology, Data management, ECRIN, European, CertificationUpdate
In 2011, ECRIN (the European Clinical Research Infra-
structure Network, funded by the EU's Seventh Framework
Programme (FP7)) published a list of standard require-
ments for data and information technology (IT) manage-
ment in trials units [1]. Their purpose is two-fold:
 to provide the basis of an ECRIN certification
programme, that is, with applicant units audited
against the standards to confirm their ability to
provide compliant and effective data management
services for multinational randomised controlled trials
(RCTs), and for ECRIN-supported trials in particular,
 to provide a clear interpretation of regulatory and
good practice requirements, in the context of the
resources available to non-commercial trials units in
Europe, and so act as a general guide to establishing
and managing high-quality data management services.
The standards were constructed by ECRIN Preparatory
Phase for Infrastructure (PPI) Working Party (WP)10, the
ECRIN working group on data centres, based on an initial* Correspondence: Christian.Ohmann@uni-duesseldorf.de
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reproduction in any medium, provided the orevaluation of a variety of international, European and na-
tional regulations and guidelines relevant to Good Clinical
Practice (GCP), data security and IT infrastructures, as well
as ECRIN documents produced previously. The group
then employed a structured and standardised approach to
generate the new standards, with several rounds of dissem-
ination, feedback, face-to-face meetings and telephone con-
ferences used to gradually iterate towards a consensus on
data centre requirements. The processes of standard con-
struction are described and discussed in detail in the paper
accompanying the list of original requirements [2].
In 2012, after two pilot audits and extensive discussion,
the ECRIN standards have been substantially revised. The
original set had 230 requirements (146 considered 'min-
imal' and a further 84 classified as 'best practice')
organised in 29 distinct lists. The revised set has now only
139 requirements (all classified as ‘essential’) organised
into 21 lists. (Please note 'standard(s)', 'requirement(s)'
and 'standard requirement(s)' are equivalent and used
interchangeably).
The standards are now also supplemented by ‘Explan-
ation and Elaboration’ (E&E) material (a term borrowed
from the CONSORT initiative [3]) to provide clarifica-
tion and justification, example scenarios, discussion of
related practice and examples of the evidence required
to demonstrate compliance.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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first provides a narrative of the pilot phase of the ECRIN
certification scheme, and then a description of the revi-
sion of the standards and the factors that drove that
revision. Additional file 1 illustrates the types of changes
made, using three example standards. The current set of
ECRIN standards is then briefly summarised. The issues
still facing standard development are discussed, as are
the methods available to develop, review and dissemin-
ate standards and possible alternative approaches for the
future. A final section discusses possible future develop-
ments. The final standards are included as supplements
to this paper: in the first, the standards are represented
as a simple list of requirements (Additional file 2); in the
second, each standard is presented with its associated
explanation and elaboration material (Additional file 3).
This dichotomy will allow users to quickly find stan-
dards and to find help for reviewing these standards.
The ECRIN pilot phase
There had always been an intention by ECRIN to pilot
the standards after their initial publication. Accordingly,
a call was launched on 1 June 2011, with a closing date
of 31 August, which invited ‘clinical trials units within
the national networks linked to ECRIN to become a
pilot centre for certification as an ECRIN data centre,
and to assist in evaluating the certification process’ [4].
At the same time, an Independent Certification Board
(ICB) was assembled to prioritise applications for audit,
oversee the certification process and make the final
certification decisions. The ICB was designed to bring
together senior staff with experience and expertise in
clinical trial quality assurance, and IT and data manage-
ment systems in particular, from a broad geographical
spread. In the end, the six members were drawn from
Spain, Italy, France, Germany, Denmark and the UK, the
membership being discussed and approved by ECRIN-
PPI WP10 members.
A small initial team of auditors was also assembled, with
the help of recommendations from ECRIN European
Correspondents as well as WP10 members. Again, exten-
sive experience and expertise in clinical trials IT and data
management systems were sought, not necessarily at the
level of seniority of the ICB members, but, for instance,
from those with responsibility for such functions within
their own unit. In the end, the initial auditor group
consisted of one from France, the UK, Sweden, Ireland
and Denmark, and three from Germany. A meeting of six
of the auditors was held in September, in Paris, to discuss
the standards and ensure that there was a shared under-
standing of the aims of the standards and audits and the
methods to be employed. Because the standards are pub-
lic, we believe we are not as reliant on the opinions of
individual auditors as in some other systems; the keyrequirement for the preparation of auditors is to ensure
they share an accurate interpretation of the standards.
One of the purposes of the pilot phase was to test this ap-
proach in practice.
Four units applied for certification in the pilot phase and
the applications were discussed by the ICB in a series of
teleconferences. Two units were selected by the board -
the Uppsala Clinical Research Centre and the Coordination
Centre for Clinical Trials, Heinrich Heine University,
Düsseldorf - and audits arranged for November 2011. In
both cases a triad of auditors was selected, with at least
one native speaker in the audited centre’s language in each
team. Audits were designed to last for three days. Auditors
were asked to give their judgement on the compliance of
the centre with each standard, providing a brief summary
of their reasoning and the evidence available in each case.
Both audits were able to be carried out within the
planned three days. In both cases the attention of audi-
tors and unit staff was focused more on the 'minimal' re-
quirements, as the ones critical for certification, rather
than those merely labelled 'best practice'. While some of
the latter were considered, it was not possible to exam-
ine them in any detail.
The audit methodology consisted largely of examining
and discussing with staff the written and electronic evi-
dence of compliance - including reading controlled doc-
uments (for example Standard Operating Procedures
(SOPs)), validation records, data extracts, allocation re-
cords, and so on - and, where appropriate, inspecting
systems and premises. Opening sessions were performed
in each case, to clarify the nature and the logistics of the
audit with centre staff, and each audit closed with a
feedback session where - on an informal basis - the audi-
tors' findings and recommendation to the ICB were
summarised.
Both audits took place primarily in English. Local docu-
ments were examined in German in the case of
Düsseldorf, but usually translated into English in Uppsala.
Both units were fully supportive of the audit process, mak-
ing staff, documents and systems fully available (without
compromising patient confidentiality) and both units
appeared to find the audit experience a positive one. In
each case auditors signed a confidentiality agreement with
the unit.
The recommendations of the auditors to the board
were similar in both cases - both units had reached al-
most all of the minimal standards for certification but
there were a few gaps which prevented immediate certi-
fication. It was felt in both cases, however, that the out-
standing issues could be successfully addressed within
four months and the units themselves agreed with this
assessment.
The ICB had previously agreed that, in such a situ-
ation, units would not have to re-apply from scratch.
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confirm the necessary changes had been made, would be
sufficient to allow certification. The recommendation of
the auditors, in both cases accepted by the ICB, was that
both units should therefore be re-audited, with the ex-
pectation that they would meet the criteria for certifica-
tion at that point.
The major recommendation, however, was that the
standards themselves needed extensive revision, to pro-
vide a clearer and more widely understood basis for
centre certification, a better basis for individual auditors
to interpret the standards, and a better guide to good
quality IT and data management in non-commercial
trials units.
The revision of the standards
A large number of comments and suggestions were
made as a result of the pilot audits (though some of the
issues had also arisen during the auditors' meeting in
September). It was felt that:
 Considered as a whole, there were too many
standards to be assessed within the three-day limits
of an ECRIN audit. In particular, the 'best practice'
standards should be dropped as they were not
essential to the certification process (and in some
cases were felt to be confusing).
 Many of the standards, as originally written, were
somewhat ambiguous or open to different
interpretations.
 Much more supporting/explanatory material was
needed for many of the standards, to clarify their
practical meaning. Such material could also be used
to discuss the 'best practice' associated with that
area of work, rather than having best practice
standards.
 In several cases, the standards appeared to be
measuring sponsor decisions and activity rather than
the quality of the data centre itself.
These issues were discussed during the post pilot
phase evaluation meeting (Brussels, December 2011),
attended by auditors and members of the ICB as well as
members of ECRIN-PPI WP9 and 10, and there was
general agreement that the standards needed to be re-
vised to meet these concerns.
Versions 2.0 and 2.1
Version 2.0 of the standards was generated in December
2011 by the chair of the ICB, to reflect the feelings of
the review meeting. The 'best practice' standards were
removed and the remaining standards re-organised to 22
distinct lists. Efforts were made to clarify and simplify
standard statements. Those standards that had beenidentified as really assessing sponsors were removed or
reworded to better reflect the data centre's contribution.
A first draft of supporting 'E&E' material was also
produced.
All documents were made available in January to those
who had expressed an interest (at the December review
meeting) in helping to revise the standards. A series of
four teleconferences was also organised to review groups
of the standards in a more structured way. The set of
standards that emerged from this exercise was labelled
as version 2.1.
There had been recognition at the December review
meeting of overlap between areas considered by ECRIN
WPs 9 and 10, in particular in standards dealing with
monitoring and pharmacovigilance. The feeling was that
it would be better to work on these areas separately,
using input from both groups, and remove them from
the current set of standards.
As a result, in version 2.1, the list of standards dealing
with pharmacovigilance was removed, leaving 21 distinct
lists, and standards dealing with monitoring were re-
stricted to the role of the data centre in supporting such
activity.
Final review and version 2.2
A final face-to-face meeting took place to complete the
review of the standards on 17 April 2012 in Brussels. All
standards were considered and several further revisions
were agreed. A few standards were the subject of contin-
ued email exchanges until the beginning of May when
agreement was finally reached. The resulting set of 139
standards, divided into 21 lists, is labelled as version 2.2
and is the current version for 2012 (see Figure 1).
The final stage was to circulate and discuss a revised set
of E&E material, and this was carried out amongst a small
group in June/July 2012 using teleconferences. Time con-
straints meant that not all of the support material was
discussed in detail, so the intention is to keep this material
under continuous review. The standards themselves, how-
ever, should only need to be reviewed and revised annu-
ally. The final standards are included as supplements to
this paper, both as a simple listing (Additional file 2) and
as the extended document with E&E material included
(Additional file 3).
Specific vocabulary
It was also necessary to develop a glossary of definitions
as part of the review process, to reduce ambiguity in the
standards.
For the most part the definitions are of relatively com-
mon terms but provide their specific meaning within the
context of the ECRIN standards. Examples include
'centre', which was used to indicate the trials units, re-
search centre, data centre (and so on) being audited,
Figure 1 Summary of the review of standards and version evolution.
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the data.
A few terms were developed specifically for the stan-
dards. The most significant of these was 'CDMA', for
'Clinical Data Management Application'. This was used to
refer to the individual database or data application set up
specifically for a trial, with all the trial particular screens
and logic checks, and was developed to clearly differenti-
ate the trial-specific applications from the underlying
Clinical Database Management System (CDMS) and the
Database Management System (DBMS) used to support it.Examples of standard revision
Additional file 1 includes three examples of standards
and their supporting material and compares their
original and final versions, explaining why the changes
were made.
The clarification of the meaning and wording of stan-
dards, the use of consistent terminology and the intro-
duction of E&E material to further explain both the
criteria and the evidence required to demonstrate com-
pliance should make future audits much easier, though
those audits will remain under review. The clarification
of the standards and their meaning should also allow tri-
als units to assess themselves against the standards
much more easily, and gain a better idea of their ability
to gain certification as an ECRIN data centre.The current ECRIN standards
The 21 lists in version 2.2 are divided into three groups,
as shown in Figure 2. Most lists have between five andten standards. The IT and data management groupings
are self-explanatory, while the ‘general’ group comprises
a mix of topics that either deal with general centre-wide
characteristics like training or span both IT and data
management, like treatment allocation.
As the double-headed arrows between the groups indi-
cate, the three groups are not distinct: in reality there is
considerable overlap between them.Standards by focus
The standards can also be grouped by their 'focus', that is
the type of requirement they represent. For instance, the
initial standard in many lists contains a requirement for a
controlled document (for example a Standard Operating
Procedure) dealing with the topic under consideration. In
total, there are 21 standards (15%) focused on the centre's
Quality Management System (QMS) by explicitly requir-
ing, as part of the standard, controlled documents cover-
ing specified topics to be available.
Very many of the other standards, however, also
include 'relevant controlled documents' amongst their
specified evidence, so a mature QMS is an essential pre-
requisite for an applicant unit.
A categorisation of the standards was carried out using
the requirement type rather than the specific procedure
or functional area responsible for its fulfillment. The
categories were defined by the author group.
As shown in Figure 3, similar proportions of standards
are concerned with maintaining data consistency and in-
tegrity (16%), data security and access control (15%), and
validation and testing (14%). Standards in all of these
Figure 2 The revised standard lists - version 2.2.
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DM and GE lists, underlining the fact that the lists over-
lap considerably in practice.
Seventeen of the standards (12% of the total) are
concerned with record keeping of some sort, including
retention of data snapshots. Other areas identified wereFigure 3 Standards grouped by 'focus'.training and support (8%), maintaining system integrity
(5%) and assuring appropriate specifications and design
(5%). Only 10% of standards do not fall within these
named groups.
Another framework within which to analyse the stan-
dards is provided by Donabedian's triad of structure,
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care [5].
If one assumes that the outputs of a data centre are
datasets that accurately reflect the study source data
then using outcome measures - in a short external audit
with no access to the original data - is very difficult, and
such measures do not appear in the standards. In fact,
127 (91%) of the 139 standards relate to process. Only
12 can be unambiguously identified as relating to struc-
tural components, though it is true that many of the
process standards are about how structural elements are
specified, configured, validated and used in practice. In
other words, the standards assume most of the relevant
structural components (for instance, a network, external
firewalls, a CDMS, and some form of treatment alloca-
tion system) are already present, and largely focus on
the procedures and people that the centre puts around
these components as indicators of quality.
Current issues with the standards
Some issues will need to be resolved as the ECRIN stan-
dards develop further:
The tension between standards for certification and
guidance: As outlined in the introduction, the ECRIN
standards were originally developed to have a dual role:
 to act as a quality assurance benchmark for
certifying units as ECRIN data centres, helping to
provide an appropriate infrastructure for ECRIN-
supported trials,
 to provide a clear description of good quality IT and
data management, especially for smaller and newer
units still developing those services, and thereby
help to raise the general standards of clinical trial
management in Europe.
It was the second role that led to the original inclusion
of 'best practice' standards. They have now been removed,
though some of their content has been included in the
E&E material, and/or the introductory material to each list
of standards. Focusing the standards more on the certifi-
cation process makes that process simpler and the audits
easier, but it means there is a risk that one of the two ori-
ginal purposes of the standards is now being sacrificed.
It will therefore be necessary to clarify the purpose of
the standards, that is to decide to either focus on the
certification function in isolation or reiterate that the
standards have their original dual role, and should there-
fore be clearly linked to developing guidance/discussion
materials. The second approach would be more coher-
ent, and offers two advantages:
 using the standards for audit should identify areas
where additional guidance would be particularlyuseful (system validation is an example of a topic
where this already seems to be the case),
 developing guidance materials can directly inform
the further development of related standards.
There will be a challenge, however, in integrating this
activity with other parts of ECRIN (for example the
ECRIN Campus initiative, designed to act as an informa-
tion resource for trials units) as well as keeping material
up to date with any changes in regulations.
Standard scope and ‘optional’ certification areas: The
current scope of the standards is limited to IT and a
relatively narrow interpretation of data management.
Activities related to monitoring and site management, as
well as pharmacovigilance and managing laboratory and
biological samples-related data, are omitted from the
current standards (apart from a single standard on
supporting SDV (Source Data Verification) by others).
This is partly a function of the historical development
of the standards and the focus of the WP10 group within
ECRIN-PPI (monitoring and pharmacovigilance were
considered by other groups), partly a recognition that
these areas are not 'core' to the data management func-
tion, and a unit could therefore be certified as an ECRIN
data centre without providing these services - the spon-
sor using other service providers as necessary.
It could be very useful to develop additional standards
to cover these 'optional' areas. Those units that wished
to provide such services (and advertise the fact to poten-
tial sponsors) could then be certified against those stan-
dards. That would change the application process
slightly, as units would then have to indicate which, if
any, of these optional areas they would want to have
audited, and the auditing team/timetable might also
need to be changed accordingly.
There are a variety of issues that remain to be re-
solved: initially there is the need to confirm that the sug-
gestion of having this additional characterisation of units
would be useful to potential sponsors. If that is the case,
then decisions are required about the best way of pro-
viding this information, that is, by using standards or
some other approach (possibly self-assessment). If stan-
dards are used, then decisions will need to be taken
about which additional sets of standards should be
developed and when.
Need for steering, development and approval
mechanisms
The standards were developed by WP10 of ECRIN-PPI,
made up of domain experts from the ECRIN member
networks. The problem is that the PPI phase of ECRIN
has now finished and WP10, and the other WPs of that
phase, no longer exist. The review of the standards was
carried out by an ad hoc collection of people drawn
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there is currently no group formally set up to either
develop or approve new standards and related material.
The certification program is planned to proceed under
the management of ECRIN-European Research Infrastruc-
ture Consortium (ERIC), the new legal entity that is funded
by health ministry monies from member states. This is
in contrast to the funding for the ECRIN-IA (Integrated
activity) programme, running from January 2012 to the end
of 2015, which is funded from EU FP7 grants. Delays in
establishing ECRIN-ERIC have meant not just a gap in the
programme itself, but also a lack of clarity about how future
developments in standards will be orchestrated and linked
to the wider ECRIN agenda.
Setting up mechanisms for directing, developing and
approving standards and related material is, therefore,
an essential early task for ECRIN-ERIC, and needs to be
done before the issues discussed above can be resolved.
Part of establishing such mechanisms depend on decid-
ing the best methods to use, as discussed below.
Methods for developing and reviewing the standards
One of the major problems in developing and discussing
the standards was the dependence on a relatively small
group of people to provide input. Though many people
could have become involved (potentially all the member-
ship of WP10, all of the auditors, all ICB members) in
practice, active input was limited to a self-selecting
group of about eight, though the standards were read by
more.
Though smaller groups are often more efficient, for a
pan-European initiative these numbers are not satisfac-
tory. Like any other project, ECRIN certification needs
shared ownership and involvement if it is to continue to
be supported, and it needs to use as wide a range of ex-
pertise and experience as possible to support the future
development of standards and supporting material.
Various methodological techniques are sometimes sug-
gested as a means of encouraging participation - the use
of Wiki-based websites, collaborative working systems
and file sharing, Delphi questionnaire methods and so
on. In fact, some of these methods were tried during the
standards development process (shared files, circulation
of spreadsheets and comment collection) and none of
them had any appreciable effect on the pattern of
participation.
It would appear that more fundamental reasons were
behind the low levels of participation in ECRIN stan-
dards development, only one of which might be classed
as 'methodological':
 Workload: most of the people asked to participate in
groups are working at fairly senior level and are
very, very busy. Taking part in an occasionaldiscussion is one thing but taking on additional
time-consuming work, outside of one's normal job,
such as reviewing and suggesting revised versions of
standards, is extremely difficult for most of the
group members.
 The size of the task: there were originally over 200
standards, and even the revised set has 139. The full
standards document, with all the E&E material, is
about 90 pages long. Expecting input on such a large
mass of material - when it is not part of normal paid
employment - is unrealistic and the scale of the task
may itself have been intimidating, discouraging
involvement.
 The meeting format: this involved teleconferences in
most cases. The experience of teleconferences was
that they could be very productive with small
groups of active participants and with well-defined
tasks, but that with groups larger than five or six,
and/or more nebulous discussion, it was very easy
for participants to become passive listeners, so that
the teleconference tended to become dominated by
a small group.
In the future it will be important to reduce these
barriers to participation whilst still retaining a reason-
ably efficient process for developing materials and deci-
sion making. Rather than trying to retain a large
'standing group' of experts, that self-selects itself down
to a small active core, it is suggested that it would be
more productive to distribute future work to distinct,
smaller and time-limited task groups.
This will be much easier moving forward because, of
course, there is now a full set of standards and associ-
ated material to act as the basis of further development.
ECRIN WP10, on the other hand, was faced with
constructing a system from nothing, and therefore had
to consider all aspects of the certification system and
standards at the same time.
There are three types of tasks that need to be carried
out:
 An annual review of the standards: the obvious
group to do this is the auditors themselves, together
with input from the certification board and ECRIN-
ERIC. The auditors have the best direct knowledge
of how the standards are interpreted and how
auditable they are in practice. They also have the
greatest incentive to make the standards clear and
workable. The review of existing standards will take
into account changes in regulations and emerging
evidence relating to best practice.
 Development of new groups of standards: if required,
for instance for areas like monitoring and
pharmacovigilance, as discussed above. This will
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time-limited task groups, under the co-ordination of
ECRIN-ERIC. Most groups should not need to exist
for longer than three months.
 Revision and development of supporting material:
sometimes because of concerns raised by auditors,
sometimes as part of the broader ECRIN goal of
raising standards in clinical trials units generally,
input may be required to develop better and/or
wider understanding of certain topics. This could
involve not just working on the 'E&E' text, but also
developing educational materials, discussion papers,
collating and comparing experience, and proposing
best practice. Again this will require domain
expertise and thus specialist task groups, and may
also require liaison with the ECRIN Campus
initiative.
As envisaged, a typical task group would be usually
asked to arrange face-to-face meetings at the beginning
and end of the process, with teleconferences (in time
perhaps video conferences) in between. Administrative,
secretarial and functional support would need to be sup-
plied from the (ECRIN-ERIC) centre. Collaborative
working should, eventually, be supported by the new
ECRIN website. Most task groups (apart from the audi-
tor group) should not need to include more than eight
members.
To encourage participation, group members should
also be given some form of public recognition as 'ECRIN
external experts', registration on the ECRIN website and
joint authorship of any papers produced by the group.
This is a more flexible and hopefully much more access-
ible structure than the previous single working group. It
will require, however, strong central support and co-
ordination. This needs to be provided at two levels:
 Executive co-ordination: part of whatever executive
structures are established in ECRIN-ERIC needs to
oversee the certification programme, and part of
that will be the continued development of the
standards. This is necessary to integrate this activity
with the rest of ECRIN and to match it against
available resources, for instance in deciding upon
the numbers and subjects of task groups. It is also
necessary to provide a clear policy context in which
further development can take place.
 Central support: recording meetings and rewriting
documents cannot be done in a reasonable time
frame unless central support is provided. A central
function has also proven very useful in creating and
circulating first drafts of material for discussion, and
in creating a variety of record, dissemination and
display systems. As central support is also requiredfor the certification/audit process, the same staff
should be used for both functions.
Both of these central co-ordinating functions should
be established soon as part of ECRIN-ERIC. The execu-
tive co-ordination and central supporting function,
together, would in effect form an ECRIN-ERIC steering
group for both the certification and standard develop-
ment process.
The future
The current standards and supporting material provide a
solid basis for future ECRIN audits but they also repre-
sent a summary of high-quality IT and data management
practice in non-commercial clinical trials. As such they
have potential value, and deserve wider consideration,
beyond the certification and audit programme, and
indeed beyond ECRIN. We hope, for instance, that the
standards will stimulate debate about trials IT and data
management, and its resourcing, amongst funders and
senior researchers, as well as providing a general bench-
mark for planning and developing these services in non-
commercial trials units throughout the EU.
The standards should therefore be disseminated more
widely - both publicly, for example via the new ECRIN
website, and within ECRIN itself, in particular to the
European Correspondents, the national representatives
of each ECRIN member state. The European Correspon-
dents are important not just because they can help to
identify auditors and task group members, but because
they can assess whether the standards might be useful
within their own countries independent of ECRIN au-
dits. Translation into some other European languages
could help with dissemination, if the resources can be
found to support this.
For example if major funders or national bodies, espe-
cially the regulatory authorities charged with carrying
out inspections of clinical trials units, can be persuaded
to endorse or even use the standards, they become much
more significant as a standard.
That would increase the attractiveness of ECRIN certi-
fication, but also means that units may wish to use the
standards in a self-assessment exercise, for example to
help prepare for inspection, which in turn means that
ECRIN should consider developing the necessary mate-
rials and proformas to support self-assessment.
There are, of course, other groups involved in formu-
lating standards, at national and international level, for
example the Society for Clinical Data Management
(SCDM) that publishes the Good Clinical Data Manage-
ment Practices (GCDMP) guide. As described in the ori-
ginal paper [2], we did consider the SCDM requirements
during the original construction of the standards, but
were concerned that copyright issues could affect their
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dards also tend to assume a global commercial context,
whereas we wanted to focus on the non-commercial
European setting. We therefore did not make use of
them at that time. Nevertheless, it would be very useful
to explore the possibilities of convergence between these
and other sets of standards and those published by
ECRIN, because the principles underlying different sets
of standards are the same, all deriving ultimately from
the International Conference on Harmonization's guide-
line on GCP. We therefore need to consider how best to
open and maintain a dialogue with relevant groups, for
instance by inviting their input into task groups and by
performing comparative reviews.
Both of these activities would help to establish the
standards in the longer term. The aim should be to cre-
ate a 'virtuous circle' whereby the standards become bet-
ter known and more widely used and discussed, increase
in significance, scope and quality, and thus become bet-
ter known and even more widely used, and so on, and
so on.
ECRIN also needs to encourage analysis of the impact
of the standards at unit, national and international level,
for instance gathering data on the costs of meeting stan-
dards as well as the perceived benefits, and assessing any
organisational impact, for example on the way IT/data
management services are organised within non-commercial
trials units. This will be difficult but would provide import-
ant information to feed back into the standard development
and management process.
Conclusions
It has been possible to provide a substantial revision of
the ECRIN standards following a successful pilot of the
original standards and the audit process. The new stan-
dards are simpler and clearer, and much better sup-
ported by explanatory material, and provide a solid basis
for future ECRIN audits, though they will need to be
kept under review.
There remain a variety of issues to be resolved,
particularly about the scope of the standards (and thus
whether additional ones should be developed) and the
best way of developing the standards and related mater-
ial in the future in order to maximise participation from
domain experts. Small task groups are seen as an effect-
ive way of moving forward, coupled with clear central
policies and support.
In the future, as well as re-activating the ECRIN certi-
fication programme, it will also be important to dissem-
inate the standards more widely, to obtain useful
external input and explore how they can best be inte-
grated into national and other frameworks to produce
the general raising of standards and quality in trial IT
and data management that is desired.Additional files
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